C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 47/54 (2006.01) A61K 31/33 (2006.01) C07C 47/548 (2006.01) C07D 213/24 (2006.01) C07D 215/12 (2006.01) C07D 217/14 (2006.01) C07D 275/03 (2006.01) C07D 295/00 (2006.01) C07D 333/10 (2006.01)
Patent
CA 2690913
Compounds which directly inhibit IRE-1.alpha. activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response and can be used as single agents or in combination therapies.
L'invention concerne des composés qui inhibent directement l'activité IRE-1a in vitro, des promédicaments et sels pharmaceutiquement acceptables de ceux-ci. De tels composés et promédicaments sont utiles pour traiter des maladies associées à la réponse de protéine non pliée et peuvent être utilisés comme agents simples ou dans des multi-thérapies.
Flynn Gary A.
Lonergan David Gregory
Pallai Peter V.
Patterson John Bruce
Zeng Qingping
Goudreau Gage Dubuc
Mannkind Corporation
LandOfFree
Ire-1alpha inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ire-1alpha inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ire-1alpha inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1826139